Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs111593423 | chr20:6008226 | A/C | 0 | 176 | 25.53 | 23.08 | 2.93 | KM Plot |
PCPG | rs111634163 | chr2:24272657 | C/T | 0.000122 | 176 | 25.28 | 27.52 | 17.43 | KM Plot |
PCPG | rs111643226 | chr13:54161194 | C/T | 0.000228 | 177 | 25.77 | 20.17 | 3.17 | KM Plot |
PCPG | rs111652870 | chr7:36152009 | T/C | 0.000433 | 177 | 25.87 | 24.5 | 14.37 | KM Plot |
PCPG | rs111662410 | chr3:195784046 | G/C | 3.0E-8 | 175 | 24.52 | 32.92 | 10.57 | KM Plot |
PCPG | rs111690269 | chr19:14728302 | T/C | 6.41E-6 | 174 | 25.6 | 24.1 | 25.17 | KM Plot |
PCPG | rs11170393 | chr12:53462596 | C/T | 4.97E-11 | 178 | 5.87 | 24.88 | 25.53 | KM Plot |
PCPG | rs11170414 | chr12:53500145 | C/T | 1.19E-10 | 175 | 25 | 27.08 | 3.05 | KM Plot |
PCPG | rs11170415 | chr12:53500267 | C/G | 1.19E-10 | 175 | 25 | 27.08 | 3.05 | KM Plot |
PCPG | rs11170416 | chr12:53500346 | A/C | 1.19E-10 | 175 | 25 | 27.08 | 3.05 | KM Plot |
PCPG | rs11170417 | chr12:53500947 | C/T | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs11170418 | chr12:53500948 | A/G | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs11170419 | chr12:53502789 | A/G | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs11170420 | chr12:53504257 | C/T | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs111705570 | chr7:1106742 | G/A | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |